Issuer · CIK 0001689375

TRDA — Entrada Therapeutics, Inc.

Recent filings

Mar 3, 2026·Form 4·Other$89.1K
TRDA/Entrada Therapeutics, Inc.
Sethuraman Natarajan · President, Research & Develop.
scoring
Mar 3, 2026·Form 4·Other$225.5K
TRDA/Entrada Therapeutics, Inc.
Doshi Dipal · CEO
scoring

← Back to all filings

TRDA (Entrada Therapeutics, Inc.) — recent insider filings — Form 4 AI